Spesana

What Spesana does

Spesana is a privately held healthcare technology company headquartered in Memphis, Tennessee, that sells a cloud-based interoperability overlay designed to integrate with existing electronic medical record (EMR) systems rather than replace them. Founded in 2020 by Carla Balch, the former CEO of Altos Solutions (the first web-based oncology EMR, sold to Flatiron Health and ultimately to Roche), Spesana targets oncology and broader specialty workflows where it aggregates fragmented patient data, prior authorization, eligibility, molecular diagnostic results, clinical trial information, and curated clinical evidence into a single point-of-care view. The platform's core product suite includes Authorize (automated prior authorization with eligibility and patient financial responsibility), Collaborate (Aggregated Patient Viewer, interprofessional consultation, digital tumor boards), Decision Support (medical education library and Real-World Evidence), Diagnostics (electronic ordering and tracking of all tests including molecular diagnostics), Revenue Cycle, and Professional Services including clinical trial support.

The company monetizes via annual SaaS subscriptions sold through enterprise field sales targeting healthcare systems, multi-state practices, life sciences companies, and revenue cycle teams, supplemented by channel partnerships with diagnostic labs and life sciences firms. AI and machine learning are applied across process automation, computer vision (including granted machine vision patents for molecular diagnostic report interpretation), predictive analytics, knowledge retrieval, and recommendation generation, with multiple integrated partner AI assets such as VisiRad XR (Imidex), KRR AI (CureMatch), and Decode Health's analytics. Founded by a team that built the first oncology EMR, Spesana competes on its overlay architecture, oncology domain depth, and partner ecosystem rather than as a system of record.

Name

Spesana

Legal name

Spesana Inc.

Website

https://spesana.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Spesana is a Memphis-based healthcare technology company offering a cloud-based interoperability overlay that integrates with existing EMRs to streamline molecular diagnostic ordering, prior authorization, clinical collaboration, and revenue cycle workflows for oncology-focused clinicians, healthcare systems, and life sciences partners.

Ownership category

akta.pro rank

Product category

Healthcare Interoperability Software

NAICS

Software Publishers (5132), Software Publishers (513210), Computer Systems Design and Related Services (54151), Custom Computer Programming Services (541511)

SIC

Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

EHR/EMR Integration & Interoperability Middleware (HL7/FHIR) (HLALAKAD)

akta.pro secondary industries

EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps (HLACAAAN), Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity) (HLACABAM), Medical Imaging AI (HDAAAEAH), AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)

Keywords

• Healthcare interoperability platform
• Clinical decision support
• Molecular diagnostics software
• Prior authorization automation
• Precision medicine workflows

Headquarters

HQ city

Memphis

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Healthcare Platform Subscription: The Spesana Healthcare Platform is offered as a SaaS solution to healthcare systems, physician practices, and life sciences companies. The platform integrates with existing EMRs and provides clinical, operational, and financial workflow solutions.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Spesana sells a cloud-based healthcare interoperability overlay platform that integrates with existing EMRs to aggregate patient data from lab information systems and molecular diagnostics, then applies AI and machine learning at the point of care. The platform includes a separate Authorize module for automated prior authorization, eligibility, and patient financial responsibility, and supports clinical collaboration, decision support, intelligent test ordering, and revenue cycle workflows for health systems, life sciences companies, diagnostic labs, and physician practices.

Product overview

Spesana offers a unified Healthcare Platform designed as an interoperability overlay that integrates with existing EMR systems. The platform aggregates all sources of healthcare data and applies AI and machine learning capabilities at the point of care. The core product portfolio includes: Authorize (intelligent prior authorization combining eligibility, financial responsibility, and pre-auth submission), Collaborate (clinical collaboration with Aggregated Patient Viewer, interprofessional consultation, and Digital Tumor Boards), Decision Support (medical education library and real-world data), Diagnostics (intelligent test ordering for all tests including molecular diagnostics), Revenue Cycle (financial solutions for insurance and prior auth), and Professional Services (clinical trial support and optimization). The platform serves clinicians, life science companies, diagnostic labs, and payers to enable precision medicine across all therapeutic areas.

Differentiator

Problem solved

Functional benefit

Products and services

• Spesana Healthcare Platform Cloud-based interoperability overlay that aggregates all sources of healthcare data, applies AI and machine learning, and integrates results at the point of care, unifying EMRs, lab information systems, and molecular diagnostics for clinical, operational, and financial stakeholders including providers, payers, life sciences, and patients.
• Authorize Intelligent and automated prior authorization solution for healthcare providers combining eligibility verification, patient financial responsibility determination, and prior authorization submission into one integrated workflow using AI, machine learning, and EMR integration to address CMS Interoperability and Prior Authorization Final Rule requirements.
• Collaborate Clinical collaboration suite providing the Aggregated Patient Viewer, interprofessional consultations for instant referrals, unlimited digital boards including tumor boards for multi-specialty collaboration, and targeted chat for communicating with specific clinicians using relevant patient information.
• Decision Support Clinical and operational decision support offering a curated Medical Education Library (Well), Real-World Data (RWD) for treatment hypothesis generation across sites of care, and enterprise-wide metrics and analytics following a data-to-knowledge-to-outcomes paradigm.
• Diagnostics Intelligent order intake solution for all tests including molecular diagnostics, providing order updates and alerts, digital results delivery, and integrated electronic workflows that replace manual test ordering processes in EMRs with electronic ordering, tracking, and reporting for precision medicine.
• Revenue Cycle Financial workflow solution covering insurance eligibility verification, patient financial responsibility determination, prior authorization submission, and performance improvement analytics to help healthcare systems and patients address evolving CMS interoperability and prior authorization requirements.
• Professional Services White-glove professional services offering clinical trial support using the Diagnostics solution, Optimization Discovery engagements to identify organizational improvements, and Healthcare Advocacy supporting voices of all healthcare stakeholders.

Quantifiable outcome

• 90% decrease in prior authorization cycle time, resulting in shorter time to diagnosis/treatment and reduction in patient stress
• +3 more outcomes

Named customers5 records

Segments1 record

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration10 records

AI capability10 records

Feature7 records

Partnerships

13 partnerships are on record, tiered core and major.

• ImidexcoreStrategic or Co-development Partner · 11 July 2024Strategic partnership to transform lung cancer detection and patient care. Imidex's VisiRad XR FDA-cleared AI detection algorithm (83% sensitivity in detecting lung nodules and masses) will be integrated with Spesana's medical data and clinical workflow platform. Collaborative clinical study design to measure AI impact on improving lung nodule detection in chest X-rays.
• HealthGatescoreStrategic or Co-development Partner · 2 April 2024Strategic partnership to advance patient care workflow solutions and digitize prior authorizations in preparation for CMS Interoperability and Prior Authorization Final Rule. Combining HealthGates' digital prior authorization solutions with Spesana's clinical workflow ecosystem to ensure right treatment for right patient at the right time. Focus on oncology and immunotherapy arenas.
• CureMatchcoreStrategic or Co-development Partner · 11 March 2024Strategic collaboration for advancement in patient care workflow solutions and integration of actionable knowledge for predictive treatments. CureMatch's KRR AI precision medicine platform will be seamlessly integrated with Spesana's clinical workflow ecosystem to provide comprehensive suite of cutting-edge tools for personalized patient treatment plans.
• VelaturacoreStrategic or Co-development Partner · 16 January 2024Pilot project combining Velatura's exchange network (connecting thousands of clinicians to critical clinical information) with Spesana's clinical workflow solutions. Aims to reduce time patients await prior authorization decisions in oncology and specialty settings. Initial rollout to 10 participants in Michigan and Missouri.
• FamGenixmajorStrategic or Co-development Partner · 18 December 2023Strategic partnership combining FamGenix's hereditary risk screening solutions (state-of-the-art pedigree & hereditary risk assessment) with Spesana's clinical workflow ecosystem. Aims to make family health histories a part of every patient's electronic health record at point of care.
• Decode HealthmajorTechnology or Integration · 22 August 2023Partnership combining Decode Health's AI and machine learning expertise with Spesana's clinical workflow solutions. Decode Health's data platform and analytics capabilities seamlessly integrate with Spesana's point-of-care solution. Focus on accelerating precision medicine with clinical trial portfolio manager enhancement.
• Oncology Care PartnersmajorTechnology or Integration · 23 May 2023Partnership with value-based care organization where OCP uses Spesana's Precision Medicine Platform to amplify digital communication between clinicians in innovative collaborative environment. Initial practice in Phoenix, Arizona with nationwide growth strategy.
• Protean BioDiagnosticsmajorTechnology or Integration · 9 May 2023Agreement to amplify Protean's mission to rapidly deploy innovative and clinically impactful tests. Protean's MAPS system will be supported by efficient ordering, tracking, and reporting workflows in addition to education and communication capabilities within Spesana's platform.
• Clinical Research AlliancemajorStrategic or Co-development Partner · 2 February 2023Partnership where CRA utilizes Spesana Healthcare Platform to enhance clinical trial solutions. Integration at point of care provides digital health tools to efficiently identify and enroll patients in clinical trials. Focus on bringing new level of care to providers, clinical trial sponsors and patients in NYC area, particularly underserved communities.
• John Verniero (CBO)coreOthers · 15 March 2022Chief Business Officer with global experience in biopharmaceutical and precision medicine industry including at Merck, Amgen and Integra Connect. Brings finance, sales, marketing, operations, access & reimbursement, business development, strategy, and analytic functions expertise.
• Court Veach (VP Sales)coreOthers · 15 March 2022Vice President of Sales bringing experience with collaborative technologies in healthcare and information technologies. 10-year U.S. Army Veteran supporting patient referral management tools and clinical trial portfolio manager.
• Allen Rasoul (VP Strategic BD)coreOthers · 15 March 2022Vice President of Strategic Business Development bringing expertise in biotech, medical devices, new business development, marketing strategies, and strategic partnerships.
• BiodesixcoreTechnology or Integration · 1 December 2021Partnership to streamline and automate use of molecular diagnostics in clinical workflows. Spesana's platform incorporates electronic ordering of Biodesix's blood-based tests including Nodify Lung nodule risk assessment tests and IQlung Testing. Includes clinical education content, virtual engagement platform, tumor board capabilities, and clinical trial management.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Redox: Healthcare API and integration platform that connects EHRs to third-party applications. Both Redox and Spesana sell interoperability overlays that sit on top of existing EMR systems to enable data exchange and workflow automation for healthcare providers.
• 1upHealth: FHIR-based healthcare data aggregation and interoperability platform. Operates in the same EHR-overlay/interoperability category as Spesana, enabling unified patient records and app connectivity.
• Health Gorilla: Clinical data interoperability platform aggregating records from multiple sources for providers and digital health companies. Highly comparable to Spesana's Aggregated Patient Viewer and EHR-aggregation positioning.
• Particle Health: Healthcare data interoperability API platform that aggregates clinical records from a national provider network. Comparable to Spesana's interoperability overlay positioning and clinical-data aggregation approach.
• Cohere Health: AI-driven prior authorization platform serving payers and providers. Directly competes with Spesana's Authorize module on digitizing and automating PA workflows, including in oncology and specialty care.
• Syapse: Precision oncology platform that connects real-world evidence, clinical decision support, and provider workflows for cancer care. Closely comparable to Spesana's oncology-focused molecular diagnostics decision support and digital tumor board offerings.

Emerging players

• Mendel: Clinical AI platform that automates chart review and decision support for healthcare providers and life sciences. Comparable emerging AI-overlay approach to Spesana, focused on structured/unstructured clinical data interpretation.

Broad incumbents

• Flatiron Health: Roche-owned oncology EHR and real-world data platform. Spesana's founder previously sold Altos Solutions to Flatiron, making it both a lineage reference and a broad incumbent in oncology-specific clinical workflow and RWD.
• Tempus AI: AI-powered precision medicine platform combining molecular testing, real-world data, and clinical decision support. Overlaps with Spesana on molecular diagnostics workflow, RWD, and decision support, but at much larger scale across multiple therapeutic areas.
• Health Catalyst: Healthcare data and analytics platform serving health systems with decision support and workflow tools. A broader incumbent operating in the same healthcare data aggregation and analytics category that Spesana's Decision Support and RWD modules target.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks3 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/spesanaco
• Xx.com/SpesanaCo

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Spesana